Philippines

11 Vaccines Approved for Use in Philippines

Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 5 countries
3 trials in 1 country
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: bloomberg.com
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik Light

Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: bloomberg.com
Inactivated

Bharat Biotech

Covaxin

Approved in 14 countries
14 trials in 2 countries
Approval Source: reuters.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Approval Source: bloomberg.com
Inactivated

Sinopharm (Wuhan)

Inactivated (Vero Cells)

Approved in 2 countries
9 trials in 7 countries
Approval Source: fda.gov.ph
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

9 in Clinical Trials in Philippines

Protein Subunit

Clover

SCB-2019

14 trials in 13 countries
Protein Subunit

Livzon Mabpharm Inc

V-01

7 trials in 3 countries
Protein Subunit

SK Bioscience Co Ltd

GBP510

6 trials in 6 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

7 trials in 4 countries
DNA

Inovio

INO-4800

9 trials in 9 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Replicating Viral Vector

Wantai

DelNS1-2019-nCoV-RBD-OPT1

5 trials in 3 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries